These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31933385)

  • 1. Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected?
    Michel M; Schattenberg JM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):93-97. PubMed ID: 31933385
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development.
    Alkhouri N
    Expert Opin Investig Drugs; 2020 Feb; 29(2):115-116. PubMed ID: 31971024
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
    Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A
    Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological treatment of nonalcoholic fatty liver disease in children.
    Crudele A; Panera N; Braghini MR; Balsano C; Alisi A
    Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1219-1227. PubMed ID: 32981386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].
    Kim SK; Kim KI; Kim SR
    Yakugaku Zasshi; 2019; 139(9):1147-1153. PubMed ID: 31474630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
    Hallsworth K; McPherson S; Anstee QM; Flynn D; Haigh L; Avery L
    J Med Internet Res; 2021 Jan; 23(1):e20491. PubMed ID: 33448929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.
    Roeb E; Geier A
    Z Gastroenterol; 2019 Apr; 57(4):508-517. PubMed ID: 30965381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: the management of paediatric nonalcoholic fatty liver disease.
    Mitchel EB; Lavine JE
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1155-70. PubMed ID: 25267322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Golabi P; Bush H; Younossi ZM
    Clin Liver Dis; 2017 Nov; 21(4):739-753. PubMed ID: 28987260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
    Patel YA; Imperial JC; Muir AJ; Anstee QM; DeBrota D; Dimick-Santos L; Filozof C; Mehta R; Sanyal AJ; Schabel E; Neuschwander-Tetri BA; Miller V;
    Gastroenterology; 2017 Sep; 153(3):621-625.e7. PubMed ID: 28757264
    [No Abstract]   [Full Text] [Related]  

  • 12. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Clin Liver Dis; 2016 May; 20(2):339-50. PubMed ID: 27063273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Dig Dis Sci; 2016 May; 61(5):1365-74. PubMed ID: 27052013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prof Jörn Schattenberg sheds light on key treatment and diagnostic approaches to nonalcoholic steatohepatitis (NASH).
    Schattenberg JM
    Expert Opin Investig Drugs; 2020 Feb; 29(2):111-113. PubMed ID: 31985310
    [No Abstract]   [Full Text] [Related]  

  • 18. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.
    Della Corte C; Liccardo D; Ferrari F; Alisi A; Nobili V
    Expert Opin Pharmacother; 2014 Dec; 15(17):2501-11. PubMed ID: 25219959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial.
    Dong F; Zhang Y; Huang Y; Wang Y; Zhang G; Hu X; Wang J; Chen J; Bao Z
    Sci Rep; 2016 Nov; 6():36783. PubMed ID: 27830836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.